Bridge Biotherapeutics to Present at the 2023 BIO International Convention ...Middle East

PR Newswire - News
Bridge Biotherapeutics to Present at the 2023 BIO International Convention
SEONGNAM, South Korea and CAMBRIDGE, Mass., May 29, 2023 /PRNewswire/ -- Bridge Biotherapeutics Inc. (KQ288330), a South Korean clinical-stage biotechnology company focused on developing novel drugs for cancer, fibrosis and inflammation, is scheduled to give a company presentation on...

Read More Details
Finally We wish PressBee provided you with enough information of ( Bridge Biotherapeutics to Present at the 2023 BIO International Convention )

Apple Storegoogle play

Also on site :

Most viewed in News


Latest News